alendronic acid 5 MG Oral Tablet

RxCUI
904425
RxNorm name
alendronic acid 5 MG Oral Tablet
Display name
alendronic acid 5 MG Oral Tablet
Full name
alendronic acid 5 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Alendronate SodiumALENDRONATE SODIUMAmneal Pharmaceuticals of New York LLCc23fb7fe-c6b9-4f77-bde7-992222b589d32021-02-02Warnings, Adverse reactionsExact identifier
rxcui: 904425

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c23fb7fe-c6b9-4f77-bde7-992222b589d3alendronate sodium 5 MG Oral Tablet [PSN] · alendronic acid 5 MG Oral Tablet [SCD] · alendronic acid 5 MG (as alendronate sodium 6.53 MG) Oral Tablet [SY]340These highlights do not include all the information needed to use ALENDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for ALENDRONATE SODIUM TABLETS. ALENDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199520210202
e6ffadda-2ace-4e99-8bb4-75631c54f39balendronate sodium 5 MG Oral Tablet [PSN] · alendronic acid 5 MG Oral Tablet [SCD] · alendronic acid 5 MG (as alendronate sodium 6.53 MG) Oral Tablet [SY]3120100305